"Sodium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.
| Descriptor ID |
D012964
|
| MeSH Number(s) |
D01.268.549.750 D01.268.557.650 D01.552.528.850 D01.552.547.725
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sodium".
Below are MeSH descriptors whose meaning is more specific than "Sodium".
This graph shows the total number of publications written about "Sodium" by people in this website by year, and whether "Sodium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 6 | 9 |
| 1994 | 1 | 2 | 3 |
| 1995 | 0 | 6 | 6 |
| 1996 | 0 | 6 | 6 |
| 1997 | 1 | 4 | 5 |
| 1998 | 3 | 3 | 6 |
| 1999 | 3 | 1 | 4 |
| 2000 | 1 | 2 | 3 |
| 2001 | 3 | 6 | 9 |
| 2002 | 3 | 9 | 12 |
| 2003 | 3 | 0 | 3 |
| 2004 | 4 | 4 | 8 |
| 2005 | 1 | 2 | 3 |
| 2006 | 0 | 4 | 4 |
| 2007 | 2 | 3 | 5 |
| 2008 | 5 | 3 | 8 |
| 2009 | 3 | 2 | 5 |
| 2010 | 4 | 0 | 4 |
| 2011 | 4 | 1 | 5 |
| 2012 | 2 | 3 | 5 |
| 2013 | 1 | 2 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 5 | 6 |
| 2016 | 0 | 7 | 7 |
| 2017 | 2 | 5 | 7 |
| 2018 | 2 | 5 | 7 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 5 | 6 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 13 | 13 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sodium" by people in Profiles.
-
The ion transporter Na+-K+-ATPase enables pathological B cell survival in the kidney microenvironment of lupus nephritis. Sci Adv. 2023 02 03; 9(5):eadf8156.
-
Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization. Circulation. 2023 Mar 07; 147(10):824-840.
-
Measuring copeptin, a surrogate for vasopressin in patients with hypertension - Can it identify those who are volume Responsive? Clin Biochem. 2023 Feb; 112:48-52.
-
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. Diabetes Care. 2022 12 01; 45(12):2991-2998.
-
Hyponatremia Is a Powerful Predictor of Poor Prognosis in Left Ventricular Assist Device Patients. ASAIO J. 2022 12 01; 68(12):1475-1482.
-
Clinical Effectiveness of Calcium Oxalate Stone Treatments. Am J Nephrol. 2022; 53(10):761-766.
-
A 43-Day-Old Male With Respiratory Distress and Acute-Onset Hypotonia. Pediatrics. 2022 11 01; 150(5).
-
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
-
Diabetes management in chronic kidney disease: a?consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2022 11; 102(5):974-989.
-
Essential metals in health and disease. Chem Biol Interact. 2022 Nov 01; 367:110173.